SABSW
USDSAB Biotherapeutics Inc. Warrant
$0.030+0.004 (16.732%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$0.026
High
$0.033
Low
$0.026
Volume
0.00M
Company Fundamentals
Industry
Biotechnology
Country
United States
Trading Stats
Exchange
NCM
Currency
USD
52-Week Range
Low $0.0257Current $0.030High $0.0334
Related News
GlobeNewswire
SAB BIO Reports Full Year 2024 Operating and Financial Results
MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), ("SAB BIO" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.